Cargando…
336. COVID-19 and Pneumocystis jiroveci Pneumonia
BACKGROUND: More accounts of opportunistic infection in COVID-19 patients are emerging. At our institution, we identified 2 COVID-19 patients with Pneumocystis jiroveci pneumonia (PJP) opportunistic infection. This prompted a review of the literature to identify trends in patient characteristics, ri...
Autores principales: | Saling, Christopher, Kasule, Sabirah N, Vikram, Holenarasipur R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643773/ http://dx.doi.org/10.1093/ofid/ofab466.537 |
Ejemplares similares
-
1233. Serious Toxicities During Antimicrobial Therapy for Disseminated Nocardia Infection in Solid Organ Transplant Recipients
por: Saling, Christopher, et al.
Publicado: (2021) -
692. Coccidioides sp. Infective Endocarditis: A Review of the Literature
por: Kasule, Sabirah N, et al.
Publicado: (2021) -
Pneumocystis jiroveci Pneumonia
por: Haque, Abida K., et al.
Publicado: (2008) -
1024. Evaluation of Atovaquone Prescribing for Pneumocystis jiroveci Pneumonia (PJP) Prophylaxis
por: Aleissa, Muneerah, et al.
Publicado: (2019) -
The Pathogenesis and Diagnosis of Pneumocystis jiroveci Pneumonia
por: Apostolopoulou, Anna, et al.
Publicado: (2022)